Ulthera receives clearance to market Ultherapy in Brazil

October 1, 2012

Ulthera is now registered in Brazil to market and distribute its UltheraSystem, which combines ultrasound imaging with focused ultrasound therapy in a treatment known as Ultherapy.

Mesa, Ariz. - Ulthera is now registered in Brazil to market and distribute its UltheraSystem, which combines ultrasound imaging with focused ultrasound therapy in a treatment known as Ultherapy.

The system is now cleared in the country to treat the face to encourage the natural formation of collagen and elastin in the skin, the company states.

“Bringing the Ulthera System into this already booming cosmetic market will greatly extend the global reach and popularity of noninvasive Ultherapy procedures,” says Matthew Likens, Ulthera president and CEO. “We anticipate - and have already experienced - high patient and physician demand for this efficacious treatment in Brazil, just as we have had in North America, Asia and Europe in our three years of commercialization to date.”

MedSystems, an importer and distributor of clinical and aesthetic medical equipment and technology, will be the exclusive distributor of the Ulthera System in Brazil. The Ulthera System is cleared by the Food and Drug Administration for use as a noninvasive treatment of the face to lift the eyebrow.

More than 1,000 Ulthera Systems have been sold around the world, and more than 100,000 treatments have been performed using it, according to Ulthera reports.